A Study Evaluating the Safety and Efficacy of Neoadjuvant and Adjuvant Tiragolumab Plus Atezolizumab, With or Without Platinum-Based Chemotherapy, in Participants With Previously Untreated Locally Advanced Resectable Stage II, IIIA, or Select IIIB Non-Small Cell Lung Cancer
Phase 2 Terminated
50 enrolled 18 charts
Nivolumab Plus Cisplatin/Pemetrexed or Cisplatin/Gemcitabine as Induction in Resectable Non-Small Cell Lung Cancer
Phase 2 Terminated
14 enrolled 16 charts
Efficacy and Safety of TQB2450 Injection Combined With Chemotherapy ± Anlotinib Hydrochloride Capsules for Advanced Endometrial Cancer or Sarcoma of Uterus.
Phase 2 Terminated
71 enrolled
Pemigatinib + Pembrolizumab vs Pemigatinib Alone vs Standard of Care for Urothelial Carcinoma (FIGHT-205)
Phase 2 Terminated
7 enrolled 10 charts
CARMEN-BT01
Phase 2 Terminated
50 enrolled 20 charts
PRESERVE3
Phase 2 Terminated
92 enrolled 24 charts
Testing the Addition of an Anti-Cancer Immunotherapy Drug, Avelumab, to Gemcitabine and Carboplatin Chemotherapy Prior to Surgery in Muscle Invasive Urinary Tract Cancer vs. Surgery Alone in Patients Who Are Not Able to Receive Cisplatin Therapy (SWOG GAP TRIAL)
Phase 2 Terminated
6 enrolled 12 charts
Ganitumab in Locally Advanced Unresectable Adenocarcinoma of the Pancreas
Phase 2 Terminated
10 enrolled 10 charts
EPIC
Phase 2 Terminated
4 enrolled 6 charts
AGEN1884 Plus AGEN2034 Combined With Cisplatin-Gemcitabine for Muscle-Invasive Bladder Cancer
Phase 2 Terminated
4 enrolled 9 charts
Chemotherapy & Bevacizumab for Human Epidermal Growth Factor Receptor 2 (HER2)/Neu-Negative Stage II/III Breast Cancer
Phase 2 Terminated
15 enrolled 9 charts
Gemcitabine Hydrochloride, and Radiation Therapy in Patients With Borderline Resectable Pancreatic Cancer
Phase 2 Terminated
23 enrolled 14 charts
Nab-paclitaxel Plus Gemcitabine as First-line Therapy for Cisplatin-ineligible or Cisplatin-incurable Advanced Urothelial Carcinoma
Phase 2 Terminated
3 enrolled 9 charts
Monoclonal Antibody RAV12 and Gemcitabine in Treating Patients With Metastatic Pancreatic Cancer
Phase 2 Terminated
2 enrolled 10 charts
Regorafenib Plus Gemcitabine in Metastatic Pancreatic Cancer
Phase 2 Terminated
2 enrolled 8 charts
Disulfiram-Copper Gluconate in Met Pancreas Cancer w Rising CA19-9 on Abraxane-Gemzar, FOLFIRINOX or Gemcitabine
Phase 2 Terminated
1 enrolled 7 charts
Trial of Atezolizumab Plus Chemotherapy After Progression on PD-1 or PD-L1 in Cisplatin-ineligible Patients With Advanced Urothelial Carcinoma
Phase 2 Terminated
6 enrolled 18 charts
Durvalumab and Standard Chemotherapy Before Surgery in Treating Patients With Variant Histology Bladder Cancer
Phase 2 Terminated
7 enrolled 9 charts
RELEASE
Phase 2 Terminated
41 enrolled 17 charts
Subsequent Line Gemcitabine and Nivolumab in Treating Participants With Metastatic Small Cell Lung Cancer
Phase 2 Terminated
14 enrolled 14 charts
Gemcitabine +/- Imatinib Mesylate, Patients w/Previously Treated Metastatic Breast Cancer
Phase 2 Terminated
49 enrolled 11 charts
CHOEP + High Dose Therapy + Auto SCT for T-Cell Lymphoma
Phase 2 Terminated
5 enrolled 7 charts
Mono Versus Polichemotherapy in Non Small Cell Lung Cancer (NSCLC) Elderly Patients
Phase 2 Terminated
108 enrolled
ARGO
Phase 2 Terminated
53 enrolled
PK,PD,Safety and Tolerability of Multiple Dose Regimens of MT-3724 With Gemcitabine and Oxaliplatin for the Treatment of Patients With Relapsed/Refractory Diffuse Large B Cell Non-Hodgkin's Lymphoma
Phase 2 Terminated
8 enrolled 9 charts
Pemetrexed and Gemcitabine in Patients With Advanced Head and Neck Cancer
Phase 2 Terminated
17 enrolled 8 charts
Single Agent Chemotherapy +/- Nivolumab in Patients With Advanced Squamous or Non-squamous NSCLC With Primary Resistance to Prior PD-1 or PDL-1 Inhibitor
Phase 2 Terminated
3 enrolled 11 charts
PGPC1
Phase 2 Terminated
60 enrolled
Trilaciclib (G1T28), a CDK 4/6 Inhibitor, in Combination With Gemcitabine and Carboplatin in Metastatic Triple Negative Breast Cancer (mTNBC)
Phase 2 Terminated
102 enrolled 51 charts
Pemetrexed Disodium, Gemcitabine, and Bevacizumab in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer
Phase 2 Terminated
39 enrolled 9 charts
Carboplatin and Gemcitabine in Treating Patients With Locally Advanced or Metastatic Breast Cancer
Phase 2 Terminated
5 enrolled
Gemcitabine Plus Ascorbate for Sarcoma in Adults
Phase 2 Terminated
10 enrolled 13 charts
Gemcitabine and S-1 for Locally Advanced Unresectable or Metastatic Pancreatic Cancer
Phase 2 Terminated
21 enrolled 8 charts
Immunotherapy and SBRT Study in Borderline Resectable Pancreatic Cancer
Phase 2 Terminated
10 enrolled
17-134
Phase 2 Terminated
32 enrolled 14 charts
Treatment of PTCL With Aggressive Induction Therapy Followed by Autologous SCT Using Denileukin Diftitox (Ontak)
Phase 2 Terminated
21 enrolled 13 charts
A Phase 2 Study of Viagenpumatucel-L (HS-110) in Patients With Non-Small Cell Lung Cancer
Phase 2 Terminated
66 enrolled 17 charts
PEGPH20, Gemicitabine and Nab-Paclitaxel for Pancreatic Ductal Adenocarcinoma
Phase 2 Terminated
3 enrolled 8 charts
A Phase II Study to Assess the Efficacy and Safety of Preoperative Chemo With Radiation Therapy for Patients With Borderline Unresectable Adenocarcinoma of the Pancreas
Phase 2 Terminated
10 enrolled 4 charts
Nedaplatin Combined With Gemcitabine in the Treatment of Recurrent and/or Metastatic Nasopharyngeal Carcinoma : a Single Arm and Phase â…¡ Clinical Trail
Phase 2 Terminated
60 enrolled
Gemcitabine Hydrochloride and Cisplatin Before Surgery in Treating Patients With Muscle Invasive Bladder Cancer
Phase 2 Terminated
32 enrolled 6 charts
PRICKLE
Phase 2 Terminated
9 enrolled
OsteoREC2015
Phase 2 Terminated
7 enrolled
HALO-IST
Phase 2 Terminated
4 enrolled
Trial of Chemotherapy and Avastin as Treatment for Women With Breast Cancer at High Risk for Relapse
Phase 2 Terminated
18 enrolled 8 charts
GSK1120212 Rollover Study
Phase 2 Terminated
159 enrolled 9 charts
Study Of PF-03084014 In Combination With Gemcitabine And Nab-Paclitaxel In Patients With Metastatic Pancreatic Adenocarcinoma Not Previously Treated With Anticancer Therapies
Phase 2 Terminated
3 enrolled 15 charts
A Phase II Study of Neo-Adjuvant Gemcitabine, Cisplatin and Bevacizumab in Stage IIIA (N2) Non-Squamous Cell Non-Small Cell Lung Cancer
Phase 2 Terminated
7 enrolled 9 charts
Trial of Paclitaxel Plus Gemcitabine and Cisplatin in Bladder Cancer
Phase 2 Terminated
3 enrolled 9 charts
Clinical Trial to Investigate the Efficacy of Treatment With Gemcitabine/Pazopanib in Patients With Biliary Tree Cancer
Phase 2 Terminated
29 enrolled